Core Nursing Explanation
This question tests the critical nursing management of a diabetic patient in the preoperative period, focusing on
glycemic control and
medication safety.
Key Concept Analysis: The core theme is preoperative management of type 2 diabetes mellitus (DM). Patients are made NPO (Nothing by mouth) to prevent aspiration during anesthesia. Oral hypoglycemic agents like
metformin and
glipizide are held to prevent intraoperative or postoperative hypoglycemia, as their effects can be prolonged and unpredictable when the patient is not eating. However, the stress of surgery, illness (bowel obstruction), and NPO status often leads to
stress-induced hyperglycemia. Uncontrolled hyperglycemia (
>180 mg/dL) impairs wound healing, increases infection risk, and can lead to complications like diabetic ketoacidosis (DKA) in type 1 DM or hyperosmolar hyperglycemic state (HHS) in type 2 DM.
Answer Rationale:
Key Point! The patient's blood glucose is
180 mg/dL, which is elevated, especially in a preoperative context. The oral medications are correctly held. The nurse's priority is to initiate an active intervention to lower this glucose level before surgery. This requires transitioning from oral agents to
insulin therapy, which provides rapid, titratable control. Therefore, contacting the physician to discuss insulin coverage (e.g., a sliding scale insulin order) is the correct and priority action.
Distractor Analysis:
Watch out for confusion! Option ① is dangerous. Administering metformin (which carries a risk of lactic acidosis, especially in hypoxic states or with renal impairment from dehydration/illness) and glipizide (a sulfonylurea that stimulates insulin secretion and can cause profound hypoglycemia during NPO) directly contradicts standard preoperative protocols and the physician's order.
Option ③ (monitoring) is a component of care but is a passive action. With a known elevated glucose and surgery imminent, the nurse must act to correct the problem, not just observe it.
Option ④ (document and proceed) neglects the nurse's responsibility to advocate for patient safety. An elevated glucose is a problem that requires intervention; documenting it without acting is inappropriate.
Related Concepts: Perioperative glycemic targets are often stricter (typically 140-180 mg/dL) to optimize outcomes. The management differs for type 1 vs. type 2 DM; type 1 patients always require basal insulin to prevent DKA. Metformin is specifically contraindicated around procedures using IV contrast dye due to the risk of contrast-induced nephropathy and subsequent lactic acidosis.
Concept Summary
| Concept | Key Point |
|---|
| Preoperative NPO | Held to prevent pulmonary aspiration. Requires holding oral medications. |
| Holding Oral Diabetic Meds | Prevents hypoglycemia during anesthesia and NPO. Metformin is also held to prevent lactic acidosis. |
| Stress Hyperglycemia | Illness, surgery, and stress hormones (cortisol, epinephrine) increase blood glucose. |
| Perioperative Glycemic Goal | Typically 140-180 mg/dL to reduce infection and promote healing. |
| Insulin Coverage | The standard for glycemic control in NPO/surgical patients due to its rapid, titratable effect. |
Side-by-Side Comparison!
| Medication | Mechanism | Preoperative Concern | Nursing Action |
|---|
| Metformin | Decreases hepatic glucose production, improves insulin sensitivity. | Risk of lactic acidosis if renal perfusion is compromised (e.g., dehydration, hypotension, contrast dye). | Hold 24-48 hours before surgery/procedure with contrast. |
| Glipizide (Sulfonylurea) | Stimulates pancreatic beta cells to secrete insulin. | High risk of hypoglycemia during NPO status as insulin secretion continues. | Hold on the morning of surgery. |
| Insulin | Facilitates glucose uptake into cells. | Risk of hypoglycemia if dosed without adequate glucose intake. | Used for active control; requires frequent glucose monitoring (e.g., every 1-2 hours perioperatively). |
Anatomy, Physiology & Pharmacology Points
Pathophysiology: Stress from surgery triggers the release of cortisol and catecholamines, which promote gluconeogenesis and glycogenolysis, raising blood glucose. Insulin resistance also increases.
Pharmacology: Sliding scale insulin (SSI) is a common "reactive" coverage method. A more proactive approach is basal-bolus insulin regimen, which is often preferred for better control.
Memory Tips
Mnemonic: S.H.I.P. for Pre-op Diabetic Care:
Stop oral meds (Hold them).
Hyperglycemia monitor (Check glucose frequently).
Insulin initiate (Get orders for coverage).
Prevent complications (Hypo/Hyperglycemia, infection).
High-Frequency NCLEX Topics
This is a classic NCLEX "priority action" question. It combines
medication safety,
preoperative care, and
chronic disease management. The NCLEX loves to test the nurse's role in identifying a problem (elevated glucose when meds are held) and taking the correct
collaborative action (contacting the physician) rather than acting independently or being passive.
Watch Out for Question Variations!
* Instead of "priority action," the question could ask for the
"nurse's understanding" of why metformin is held (risk of lactic acidosis).
* The scenario could change to a
type 1 diabetic. The correct action would then be to ensure the patient receives
basal insulin to prevent DKA, even if NPO.
* The blood glucose could be
60 mg/dL (hypoglycemic). The priority would then be to treat the hypoglycemia with IV dextrose or oral glucose gel if conscious, and hold all diabetic medications.